Market Place
Sourcing Support
All News #Library
Biotech
Genmab Sheds Another Clinical ADC From $1.8B Profoundbio Buy
17 Nov 2025 //
FIERCE BIOTECH
Genmab Discards ADC from $1.8 B ProfoundBio Buy
17 Sep 2025 //
FIERCE BIOTECH
Genmab buys ProfoundBio for $1.8B
04 Jun 2024 //
PRESS RELEASE
ProfoundBio to Present Data on Preclinical Programs at the AACR Meeting 2024
04 Apr 2024 //
PR NEWSWIRE
Genmab bulks ADC pipeline with $1.8-billion purchase of ProfoundBio
04 Apr 2024 //
GLOBENEWSWIRE
Seattle biotech nabs $112M for four clinical-stage ADCs
13 Feb 2024 //
ENDPTS
ProoundBio Announces First Patient Dosed in Phase 1/2 Clinical Trial of PRO1107
05 Feb 2024 //
PR NEWSWIRE
ProfoundBio Presents Promising Data on ADC Programs
03 Nov 2023 //
BUSINESSWIRE
ProfoundBio Announces Upcoming Scientific Presentations at SITC 2023
28 Sep 2023 //
PR NEWSWIRE
ProfoundBio Announces Further Advancement of Lead Programs - PRO1184
26 May 2023 //
PR NEWSWIRE
ProfoundBio Announces Initiation of First-in-Human Trial for PRO1184
03 Jan 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.